Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Neuro-OncologyOpen Access

Exploring the Glioma M6a Rna Epitranscriptome With Direct Rna Sequencing

View Full Paper
Ask AI
Bookmark
Share

Authors

SDSimon DeaconMRMasar RadhiLWLauryn Walker

Discussion

Loading...

Member takes

Overview

Direct RNA sequencing reveals m6A methylation patterns in glioma cells, suggesting novel therapeutic avenues.

Key Points

  • Direct RNA sequencing identifies m6A methylation profiles in glioma cell lines, enhancing understanding of tumor biology.
  • Robust reduction in m6A modifications was observed after treatment with a METTL3 inhibitor, indicating potential therapeutic effects.
  • Comparative analysis shows differential expression of RNA metabolism processes linked to m6A inhibition, highlighting treatment implications.
  • This approach reveals transcriptome-wide inter-tumoral heterogeneity in m6A signatures, suggesting individualized treatment potential.

Cite This Study

Deacon et al. (2025) studied this question.

synapsesocial.com/papers/68c23abeb210217d6478157dhttps://doi.org/10.1093/neuonc/noaf185.058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1M6A RNA METHYLATION AS A THERAPEUTIC TARGET IN HIGH GRADE GLIOMA2025
  2. 2Abstract P75: THE ROLE OF SETD2 IN THE MOLECULAR ONCOGENESIS OF GLIOMA THROUGH m6A RNA MODIFICATION2025
  3. 3M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges2025
  4. 4From Detection to Prediction: Advances in m6A Methylation Analysis Through Machine Learning and Deep Learning with Implications in Cancer2025
  5. 5The m6A modification in cancer: roles, implications, and its potential in therapy2025